| | | Copy number gain | See cases | |
| | LOC130067011, LOC130067012 +535 more | Copy number gain | See cases | |
| | LOC126863153, LOC126863154 +2088 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +798 more | Copy number gain | See cases | |
| | LOC130067137, LOC130067138 +823 more | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Duplication | Schizophrenia | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | IGLV4-3, LINC01659 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +160 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +160 more | Copy number gain | See cases | GConflicting classifications of pathogenicity |
| | ADORA2A, ADORA2A-AS1 +162 more | Copy number gain | See cases | |
| | LOC130067089, LOC130067090 +160 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +157 more | Copy number gain | See cases | |
| | LOC130067070, LOC130067071 +124 more | Copy number gain | See cases | |
| | LOC130067246, LOC130067247 +556 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +84 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +81 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +81 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +80 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +80 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +80 more | Copy number gain | See cases | |
| | | Duplication | Schizophrenia | |
| | | Duplication | Schizophrenia | |
| | LOC130067107, LOC130067108 +74 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +76 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +76 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +70 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +76 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | GConflicting classifications of pathogenicity |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +57 more | Copy number gain | See cases | |
| | | Deletion (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (G9A) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L-ADORA2A, SPECC1L (V14A) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | SPECC1L-related condition +1 more | |
| | SPECC1L, SPECC1L-ADORA2A (T20M) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (E29D) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +1 more | |
| | SPECC1L-ADORA2A, SPECC1L (T36A) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L, SPECC1L-ADORA2A (G44E) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (K51R) | Single nucleotide variant (missense variant +1 more) | SPECC1L-related condition | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (T52S) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (S55I) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (V72I) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (S77N) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L-ADORA2A, SPECC1L (T78I) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (S98F) | Single nucleotide variant (non-coding transcript variant +1 more) | Teebi hypertelorism syndrome +3 more | GConflicting classifications of pathogenicity |
| | SPECC1L, SPECC1L-ADORA2A (I100F) | Single nucleotide variant (non-coding transcript variant +1 more) | SPECC1L-related syndrome | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (T104A) | Single nucleotide variant (non-coding transcript variant +1 more) | SPECC1L-related condition +1 more | |
| | SPECC1L, SPECC1L-ADORA2A (K109R) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L, SPECC1L-ADORA2A (R110Q) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L-ADORA2A, SPECC1L (S111G) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L, SPECC1L-ADORA2A (S111R) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | SPECC1L-related condition | |
| | SPECC1L, SPECC1L-ADORA2A (S121F) | Single nucleotide variant (non-coding transcript variant +1 more) | SPECC1L-related condition +1 more | |
| | SPECC1L, SPECC1L-ADORA2A (R123G) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R125G) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (Q143*) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R155C) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R155H) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R155L) | Single nucleotide variant (missense variant +1 more) | Malignant tumor of prostate | |
| | SPECC1L, SPECC1L-ADORA2A (R157Q) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (V164I) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R165H) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (M166V) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases +2 more | |
| | SPECC1L-ADORA2A, SPECC1L (M166fs) | Deletion (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (K170E) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L, SPECC1L-ADORA2A (D172N) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (R178fs) | Microsatellite (non-coding transcript variant +1 more) | SPECC1L-related condition +1 more | |
| | SPECC1L, SPECC1L-ADORA2A (A180G) | Single nucleotide variant (non-coding transcript variant +1 more) | Teebi hypertelorism syndrome 1 | |
| | SPECC1L, SPECC1L-ADORA2A (K184R) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (K184T) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (V185E) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L-ADORA2A, SPECC1L (L188F) | Single nucleotide variant (non-coding transcript variant +1 more) | Oculomaxillofacial dysostosis +2 more | |
| | SPECC1L, SPECC1L-ADORA2A (T190M) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (synonymous variant +1 more) | Teebi hypertelorism syndrome +3 more | |
| | SPECC1L, SPECC1L-ADORA2A (K193R) | Single nucleotide variant (non-coding transcript variant +1 more) | Teebi hypertelorism syndrome 1 | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | SPECC1L, SPECC1L-ADORA2A (L200F) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +2 more | |
| | SPECC1L-ADORA2A, SPECC1L (M209T) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases | |
| | SPECC1L-ADORA2A, SPECC1L (R210H) | Single nucleotide variant (non-coding transcript variant +1 more) | Inborn genetic diseases +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |